This makes KIT an attractive target for NB therapy, since several drugs, which can target KIT are used for chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GIST) and kidney cancers [20]. The gene discussed is KIT; the disease is neuroblastoma.